webinar register page

Webinar banner
Improving access to NTD health products to achieve the 2030 road map targets
The availability, accessibility, acceptability, and affordability of medicines and vaccines of assured quality need to be addressed to achieve the 2030 road map targets and the Sustainable Development Goals. The 2030 NTD roadmap recognizes ‘Access to quality-assured NTD Health Products and efficient Supply Chain Management (SCM)’ as a priority area that requires critical and coordinated action.

This webinar will highlight what is being done to ensure the safe delivery of quality assured NTD medicines and health products to more than a billion people annually. It will bring together experts from various fields to assess gaps, challenges and progress and the areas that require urgent and ongoing attention.

The webinar will also hear from officials from ministries of health of countries endemic for NTDs as well as implementing partners on best practices, challenges and possible solutions.
* Required information


Cassandra Holloway
Project Support Specialist @The Task Force for Global Health
Cassandra Holloway is Project Support Specialist at the Neglected Tropical Diseases Supply Chain Forum – a public-private partnership that includes some of the world’s leading experts in pharmaceutical supply chain systems for donated medicines. Ms Holloway has years of experience in project management, accounting, budgeting, and data analysis. After her studies, she worked for several years in the private sector, managing large scale commercial real estate projects.
Tijana Williams
Director, Albendazole Donation Programmes @GlaxoSmithKline, United Kingdom
Tijana Williams is Director of NTD programmes at GlaxoSmithKline (GSK) and currently responsible for the delivery of GSK’s commitments towards global Lymphatic Filariasis (LF) elimination and the Soil Transmitted Helminths (STH)
Fatima Ait Bendawad
Head, DHL Global Humanitarian Logistics Competency Centre @DHL Global Forwarding, United Arab Emirates
Fatima Ait Bendawad leads DHL’s Global Humanitarian Logistics Competence Centre in Dubai, United Arab Emirates. Ms Ait Bendawad is responsible for overseeing the deployment of DHL’s humanitarian logistics services globally. She has over 18 years of experience in international logistics in the Middle East within operations, business development, sales and marketing in aid and relief supply chain. She works closely with NGOs, UN agencies and several humanitarian organizations.
Modeste Tezembong
Supply Chain Management Officer @WHO AFRO
Modeste Tezembong is a health logistics and procurement and supply management advisor. Mr Tezembong currently serves as focal point for supply chain management at WHO’s Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN). Prior to joining ESPEN, he worked for several organizations and entities. Mr Tezembong holds a master’s degree as well as a post-graduate diploma in logistics and strategic supply chain.
Boubacar Diop
Pharmacist logistician/coordinator @Ministry of Health, Senegal
Boubacar Diop holds a doctorate in Pharmacy. He serves as head pharmacist in the Ministry of Health and Social Action in Senegal. Dr Diop served as coordinator of the national programme for the control of bilharziasis and soil-transmitted helminthiases. He also played an important role in revising the standard operating procedures for the management of NTD medicines in Senegal and contributed to the evaluation of mass distribution campaigns of Praziquantel in areas of northern Senegal.
Sultani H. Matendechero
Head, Kenya Centre for Disease Control @National Public Health Institute of Kenya
Sultani Hadley Matendechero is a senior pharmacist with a masters in Clinical Pharmacy from the University of Nairobi. He is the head of the Kenya Centre for Disease Control, which is the National Public Health Institute of Kenya. Dr Sultani has previously served as National NTD program pharmacist and later, National NTD program manager in Kenya. He currently sits on the WHO Advisory Group on STH and Schistosomiasis Control and Elimination and served as the inaugural chairperson of the African NTD program managers Community of Practice.
Mawo Fall
Chief of Party, USAID’s 'Act to End NTDs - East Program' @RTI International, Mozambique
Mawo Fall has over 15 years’ managerial and technical experience in health programming in several countries. In his current role, Dr. Fall serves as Chief of Party on USAID’s Act to End Neglected Tropical Diseases | East program in Mozambique. He also provides technical support to the Mozambique’s Ministry of Health at the central, provincial and district levels. His collaborative approach has permitted him to develop strong relationships with partners.  Dr. Fall is fluent in English, French, and Portuguese.
Fabienne Jouberton
Pharmacist, Tuberculosis & NTDs @Médecins Sans Frontières, Geneva, Switzerland
Fabienne Jouberton, is a pharmacist with more than 30 years’ experience in pharmaceutical management, with a focus on access to health products. She worked for 12 years at WHO and the Global Fund, mainly on innovative mechanisms for accessing TB, Malaria and HIV products. At Médecins Sans Frontières, Ms Jouberton provides technical support on pharmaceuticals for tuberculosis and NTDs.
Penny Smith
Senior Advisor Infectious Diseases/NTDs Division @USAID, Washington, DC
Penny Smith is Senior Advisor with USAID and serves as the supply chain and supports global efforts to ensure access to high quality NTD medicines. Prior to USAID, Ms Smith worked for NGOs in HIV prevention, care and treatment, primary health care and supply chain systems. She holds a Master of Public Health degree from Emory University and is a Certified Health Education Specialist
Laurent Fraisse
Director, Research & Development @Drugs for Neglected Tropical Diseases Initiative, Geneva, Switzerland
Laurent Fraisse is Director for R&D at Drugs for Neglected Diseases initative. Dr Fraisse has worked in the field of infectious diseases since 2002. Prior to joining DNDi, he worked as Research Scientist. His work has contributed to addressing high unmet medical needs in bacterial, parasitic, and viral related infections. Most recently, he worked as Global Head of Infectious Disease R&D at Evotec.